Follow-up of Clinical Symptoms and Blood Concentration in Donepezil Overdose

References (9)

1. Kosasa T, Kuriya Y, Yamanishi Y. Effect of donepezil hydrochloride (E2020) on extracellular acetylcholine concentration in the cerebral cortex of rats. Jpn J Pharmacol. 1999;81(2):216–222. PubMed CrossRef
2. Rogers SL, Friedhoff LT. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses. Br J Clin Pharmacol. 1998;46(suppl 1):1–6. PubMed CrossRef
3. Wilson RS, Boyle PA, Yu L, et al. Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology. 2015;85(11):984–991. PubMed CrossRef
4. Mitchell RJ, Harvey LA, Brodaty H, et al. Dementia and intentional and unintentional poisoning in older people: a 10-year review of hospitalization records in New South Wales, Australia. Int Psychogeriatr. 2015;27(11):1757–1768. PubMed CrossRef
5. Noetzli M, Eap CB. Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer’s disease. Clin Pharmacokinet. 2013;52(4):225–241. PubMed CrossRef
6. Tiseo PJ, Rogers SL, Friedhoff LT. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration. Br J Clin Pharmacol. 1998;46(suppl 1):13–18. PubMed CrossRef
7. Bures J, Tacheci I, Kvetina J, et al. The impact of dextran sodium sulfate-induced gastrointestinal injury on the pharmacokinetic parameters of donepezil and its active metabolite 6-o-desmethyldonepezil, and gastric myoelectric activity in experimental pigs. Molecules. 2021;26(8):2160. PubMed CrossRef
8. Shintani EY, Uchida KM. Donepezil: an anticholinesterase inhibitor for Alzheimer’s disease. Am J Health Syst Pharm. 1997;54(24):2805–2810. PubMed CrossRef
9. Patel BN, Sharma N, Sanyal M, et al. Quantitation of donepezil and its active metabolite 6-O-desmethyl donepezil in human plasma by a selective and sensitive liquid chromatography-tandem mass spectrometric method. Anal Chim Acta. 2008;629(1-2):145–157. PubMed CrossRef